• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Catholic Review

Catholic Review

Inspiring the Archdiocese of Baltimore

Menu
  • Home
  • News
        • Local News
        • World News
        • Vatican News
        • Obituaries
        • Featured Video
        • En Español
        • Sports News
        • Official Clergy Assignments
        • Schools News
  • Commentary
        • Contributors
          • Question Corner
          • George Weigel
          • Elizabeth Scalia
          • Michael R. Heinlein
          • Effie Caldarola
          • Guest Commentary
        • CR Columnists
          • Archbishop William E. Lori
          • Rita Buettner
          • Christopher Gunty
          • George Matysek Jr.
          • Mark Viviano
          • Father Joseph Breighner
          • Father Collin Poston
          • Robyn Barberry
          • Hanael Bianchi
          • Amen Columns
  • Entertainment
        • Events
        • Movie & Television Reviews
        • Arts & Culture
        • Books
        • Recipes
  • About Us
        • Contact Us
        • Our History
        • Meet Our Staff
        • Photos to own
        • Books/CDs/Prayer Cards
        • CR Media platforms
        • Electronic Edition
  • Advertising
  • Shop
        • Purchase Photos
        • Books/CDs/Prayer Cards
        • Magazine Subscriptions
        • Archdiocesan Directory
  • CR Radio
        • CR Radio
        • Protagonistas de Fe
        • In God’s Image
  • News Tips
  • Subscribe
The headquarters of the U.S. Department of Health and Human Services is seen in Washington in this file photo. On Dec. 18, 2025, the agency announced new regulatory actions that would effectively ban certain types of medical or surgical gender reassignment procedures for minors who identify as transgender. (OSV News photo/Nancy Phelan Wiechec)

HHS proposes new regulatory actions to prohibit gender transition procedures for minors

December 19, 2025
By Kate Scanlon
OSV News
Filed Under: Health Care, News, Respect Life, World News

WASHINGTON (OSV News) — The U.S. Department of Health and Human Services Dec. 18 announced new regulatory actions that would effectively ban certain types of medical or surgical gender reassignment procedures for minors who identify as transgender.

HHS and the Centers for Medicare & Medicaid Services issued a proposed regulation to bar hospitals from performing gender transition surgeries or providing hormonal treatments for minors experiencing gender dysphoria as a condition of participation in Medicare and Medicaid programs. Almost all hospitals in the U.S. participate in these programs.

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. speaks during a news conference at the HHS headquarters in Washington Nov. 10, 2025. The agency on Dec. 18 announced new regulatory actions that would effectively ban certain types of medical or surgical gender reassignment procedures for minors who identify as transgender. (OSV News photo/Elizabeth Frantz, Reuters)

However, the regulations are not yet final or legally binding — they must first undergo a rulemaking process, including public comment. They are also expected to face legal challenges.

HHS Secretary Robert F. Kennedy Jr. said at a Dec. 18 press conference that “so-called ‘gender affirming care’ has inflicted lasting, physical and psychological damage on vulnerable young people.”

HHS said the proposed regulatory actions were designed to carry out President Donald Trump’s executive order that sought to prohibit these procedures for minors.

Supporters of banning gender transition surgeries or hormonal treatments for minors who identify as transgender say such restrictions will prevent them from making irreversible decisions as children that they may come to regret as adults. Critics of such bans argue that preventing those interventions could cause other harm to minors, such as mental health issues or increase the risk of physical self-harm.

The U.S. bishops approved in November an updated version of their guiding document on Catholic health care, with substantial revisions that include explicit prohibitions against so-called “gender-affirming care.”

The proposed revisions of the “Ethical and Religious Directives for Catholic Health Care Services,” build on “Dignitas Infinita,” the 2024 declaration on human dignity published by the Vatican’s Dicastery for the Doctrine of the Faith.

“Dignitas Infinita” reaffirmed church teaching on gender, describing sexual difference as “the greatest possible difference that exists between living beings,” which in humans “becomes the source of that miracle that never ceases to surprise us: the arrival of new human beings in the world.”

In guidance on health care policy and practices released in March 2023, the U.S. Conference of Catholic Bishops’ Committee on Doctrine stated the church’s opposition to interventions that “involve the use of surgical or chemical techniques that aim to exchange the sex characteristics of a patient’s body for those of the opposite sex or for simulations thereof.”

“Any technological intervention that does not accord with the fundamental order of the human person as a unity of body and soul, including the sexual difference inscribed in the body, ultimately does not help but, rather, harms the human person,” the document states.

A 2022 study by the UCLA Williams Institute found there are approximately 1.6 million people in the U.S. who identify as transgender, including about 300,000 youth (those 13-17 years old) who identify as transgender.

A recent JAMA Pediatrics study found 926 U.S. adolescents with commercial insurance and a gender-related diagnosis received puberty blockers from 2018 through 2022, and none of them were under the age of 12. The study did not include minors covered by Medicaid.

Twenty-six states and Puerto Rico already ban or restrict such procedures, according to data from the Movement Advancement Project, an LGBTQ+ policy group.

The announcement came as HHS faced criticism for cutting millions of dollars in grants to the American Academy of Pediatrics after that group criticized Kennedy’s changes to federal vaccine policy.

HHS has also recently faced criticism from some pro-life activists for the Food and Drug Administration‘s recent approval of a new generic form of mifepristone, a pill commonly, but not exclusively, used for early abortion. FDA falls under HHS purview.

Read More Health Care

Bioethics of the brain: A conversation with a Catholic neurosurgeon

Ave Maria University battles measles outbreak

March for Life rally, national shrine, CUA among infection sites for confirmed measles cases in D.C.

Two major medical groups back limits on gender transition procedures for minors

Trump administration ends federally funded research with fetal tissue from elective abortions

Ohio nuns lament downfall of their former nursing home under new owners

Copyright © 2025 OSV News

Print Print

Primary Sidebar

Kate Scanlon

Click here to view all posts from this author

For the latest news delivered twice a week via email or text message, sign up to receive our free enewsletter.

| MOST POPULAR |

  • ‘Unborn children are dying’: Pro-life leaders challenge ICE detention of pregnant women

  • Deacon Jack Ames, Project Rachel volunteer and educator, dies at 74

  • A quick guide to fasting in Lent

  • ‘Remember you are dust’: Why people fill the pew on Ash Wednesday

  • Archdiocese of Baltimore couples share stories of love that lasts a lifetime 

| Latest Local News |

Baltimore chapter of Young Catholic Professionals celebrates successful first year

Mount St. Joseph’s BJ Ransom selected as BCL Player of Year; league unveils new academic honors

Radio Interview: Archbishop Lori’s pastoral letter: ‘In Charity and Truth’

St. Carlo Acutis Camping Retreat builds faith in the great outdoors 

Notre Dame Prep develops new commons area

| Latest World News |

Holy See will not join Trump’s ‘Board of Peace’ for Gaza, Cardinal Parolin says

Pope Leo XIV calls for ‘countercultural’ repentance on first Ash Wednesday of his pontificate

Bishops praise Virginia Legislature for halting assisted suicide bill

Diocese of Camden reaches ‘long overdue’ $180 million abuse settlement

Death is close; Jesus and his love are closer, say clergy in Ukraine war zone

| Catholic Review Radio |

Footer

Our Vision

Real Life. Real Faith. 

Catholic Review Media communicates the Gospel and its impact on people’s lives in the Archdiocese of Baltimore and beyond.

Our Mission

Catholic Review Media provides intergenerational communications that inform, teach, inspire and engage Catholics and all of good will in the mission of Christ through diverse forms of media.

Contact

Catholic Review
320 Cathedral Street
Baltimore, MD 21201
443-524-3150
mail@CatholicReview.org

 

Social Media

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Recent

  • Holy See will not join Trump’s ‘Board of Peace’ for Gaza, Cardinal Parolin says
  • Pope Leo XIV calls for ‘countercultural’ repentance on first Ash Wednesday of his pontificate
  • Bishops praise Virginia Legislature for halting assisted suicide bill
  • Diocese of Camden reaches ‘long overdue’ $180 million abuse settlement
  • Question Corner: Why doesn’t the Church require more demanding fasting for Lent?
  • Death is close; Jesus and his love are closer, say clergy in Ukraine war zone
  • Olympic ski jumping silver, bronze medals lay on altar as young athlete’s faith goes viral
  • Remembering Angelo Gugel
  • Movie Review: ‘The Strangers – Chapter 3’

Search

Membership

Catholic Media Assocation

Maryland-Delaware-DC Press Association

The Associated Church Press

© 2026 CATHOLIC REVIEW MEDIA, ALL RIGHTS RESERVED